Clover Health's Mixed Q3: Revenue Surges, EBITDA Falls
Update: 2025-11-05
Description
Despite reporting a 50% increase in sales and beating analyst predictions, Clover Health's stock plummeted 17.5% due to lower-than-expected EBITDA and disappointing full-year guidance. The company's operating and free cash flow margins also declined, but it did see an increase in its customer base. Clover Health remains focused on long-term growth through its technology-powered services for Medicare Advantage seniors.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
